COMPARATIVE ASSESSMENT OF THE FREQUENCY OF CLINICAL MANIFESTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
Keywords:
immune thrombocytopenia, Surkhandarya region, clinical presentationAbstract
Objective: To analyze and compare the frequency of clinical manifestations in patients with immune thrombocytopenia depending on the severity of the disease.
Materials and methods: The study included 91 patients diagnosed with ITP in medical institutions of the Surkhandarya region from 2020 to 2024. Methods included clinical, laboratory, morphological, and statistical studies.
Results: Manifestations of hemorrhagic syndrome were observed in almost all patients with ITP, characterized by both skin and mucosal phenomena in the form of bruises and petechiae, as well as bleeding ranging from nasal to internal and renal variants. The severity and duration of the hemorrhagic syndrome corresponded to the severity of thrombocytopenia, being more pronounced in moderate and severe forms.
References
1. D.S. Matkarimova, D.E. Juraeva, M.I. Nabiyeva. General overview and state of the problem of immune thrombocytopenia prevalence. // Journal of Humanities and Natural Sciences. No5 (11), 2023.
2. Bussel J. et al. Immune thrombocytopenia //Expert review of hematology. - 2021. - Vol. 14. - No. 11. - P. 1013-1025.
3. Dai F. et al. Clinical features of secondary immune thrombocytopenia associated with primary Sjögren's syndrome //Frontiers in Medicine. - 2020. - Vol. 7. - P. 138.
4. Djuraeva D.E., Matkarimova D.S., Boboev K.T. Genes of the Integrin Family of Platelet Receptors (ITGA2 (C807T) and ITGβ3 (T1565C)): Features of Distribution and Analysis of the Role in Immune Thrombocytopenia//American Journal of Medicine and Medical Sciences 2025, 15 (2): 346-350.
5. Ito S. et al. Evaluation of thrombotic events in patients with immune thrombocytopenia //Annals of hematology. - 2020. - Vol. 99. - P. 49-55.
6. Kohli R., Chaturvedi S. Epidemiology and clinical manifestations of immune thrombocytopenia //Hämostaseologie. - 2019. - Vol. 39. - No. 03. - P. 238-249.
7. Machin N. et al. Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: a NIS study //Thrombosis Research. - 2018. - Vol. 172. - P. 80-85.
8. Martínez-Carballeira D. et al. Pathophysiology, clinical manifestations and diagnosis of immune thrombocytopenia: contextualization from a historical perspective //Hematology Reports. - 2024. - Vol. 16. - No. 2. - P. 204-219.
9. Palau, J.; Sancho, E.; Herrera, M.; Sanchez, S.; Mingot, M.E.; Upegui, R.I.; Rodriguez Salazar, M.J.; de la Cruz, F.; Fernandez, M.C.; Gonzalez Lopez, T.J.; et al. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study. Hematology 2017, 22, 484-492.
10. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3 (22):3780-3817.
11. Shaw J. et al. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States //Platelets. - 2020. - Vol. 31. - No. 3. - P. 307-314.
12. Wu S. R. et al. Incidence, clinical characteristics, and associated diseases in patients with immune thrombocytopenia: a nationwide population-based study in Taiwan //Thrombosis Research. - 2018. - Vol. 164. - P. 90-95.
